Back
Caribou Biosciences Vs. Beam Therapeutics Industry Stock Comparison
Buy
52
CRBU
Caribou Biosciences
Last Price:
2.09
Seasonality Move:
-20.16%
Sell
32
BEAM
Beam Therapeutics
Last Price:
25.51
Seasonality Move:
33.43%
Buy
52
Caribou Biosciences (CRBU)
is a Buy
Is Caribou Biosciences a Buy, Sell or Hold?
- The current Caribou Biosciences [CRBU] share price is $2.10. The Score for CRBU is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CRBU is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Beam Therapeutics (BEAM)
is a Sell
Is Beam Therapeutics a Buy, Sell or Hold?
- The current Beam Therapeutics [BEAM] share price is $25.58. The Score for BEAM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- BEAM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRBU Stock Price Chart
What is Caribou Biosciences's stock price today?
-
The Caribou Biosciences share price today is $2.10
The current trend is relatively stagnant and CRBU is experiencing slight selling pressure.
BEAM Stock Price Chart
What is Beam Therapeutics's stock price today?
-
The Beam Therapeutics share price today is $25.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing slight selling pressure.
CRBU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 52.87 | Buy |
| Chaikin Money Flow: | -89783 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.9 - 2.18) | Buy |
| Bollinger Bands (100): | (1.7 - 3.06) | Sell |
BEAM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 51.7 | Buy |
| Chaikin Money Flow: | -293739 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.86 - 26.18) | Buy |
| Bollinger Bands (100): | (22.57 - 27.27) | Buy |
CRBU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.97 | Buy |
| 20-day SMA: | 2.04 | Buy |
| 50-day SMA: | 2.11 | Sell |
| 200-day SMA: | 4.08 | Sell |
| 8-day EMA: | 2.03 | Buy |
| 20-day EMA: | 2.03 | Buy |
| 50-day EMA: | 2.14 | Sell |
| 200-day EMA: | 3.52 | Sell |
BEAM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.55 | Buy |
| 20-day SMA: | 25.17 | Buy |
| 50-day SMA: | 26.23 | Sell |
| 200-day SMA: | 27.36 | Sell |
| 8-day EMA: | 25.07 | Buy |
| 20-day EMA: | 25.13 | Buy |
| 50-day EMA: | 25.51 | Buy |
| 200-day EMA: | 26.96 | Sell |
Caribou Biosciences Earnings Growth & CRBU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.53 per share, and a decrease next year of $0.12 per share.
Beam Therapeutics Earnings Growth & BEAM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.46 per share, and an increase next year of $0.07 per share.
Caribou Biosciences Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Beam Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||